XML 49 R35.htm IDEA: XBRL DOCUMENT v3.22.4
Significant Accounting Policies (Details)
12 Months Ended
Dec. 31, 2022
USD ($)
Segment
Dec. 31, 2021
USD ($)
Dec. 31, 2020
USD ($)
Significant Accounting Policies [Line Items]      
Impairment of Long-Lived Assets | $ $ 0 $ 0 $ 0
Number of operating segment | Segment 1    
Total Revenues [Member] | Neurocrine Biosciences [Member] | Product Concentration Risk [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage 100.00% 84.00% 100.00%
Total Revenues [Member] | Pacira BioSciences [Member] | Product Concentration Risk [Member]      
Significant Accounting Policies [Line Items]      
Concentration Risk, Percentage   16.00%